Search Within

Laura Hong Tang

  1. "Body Imaging Service"
Formats
  1. Journal Article (13)
  2. Meeting Abstract (7)
Groups
  1. Body Imaging Service (20)
  2. Department of Pathology and Laboratory Medicine (20)
  3. Radiology, Department of (20)
  4. Department of Medicine (19)
  5. Gastrointestinal Oncology Service (19)
  6. Solid Tumor Oncology Division (19)

More Groups

People
  1. Marinela Capanu (12)
  2. Kinh Gian Do (9)
  3. David Kelsen (7)
  4. Eileen O'Reilly (7)
  5. Joanne Chou (7)
  6. Viktoriya Paroder (7)

More People

Years
  1. 2024 (2)
  2. 2023 (2)
  3. 2022 (1)
  4. 2021 (2)
  5. 2020 (1)
  6. 2018 (3)

More Years

Publications
  1. Journal of Clinical Oncology (6)
  2. Annals of Surgical Oncology (2)
  3. Annals of Oncology (1)
  4. Breast Journal (1)
  5. Cancer (1)
  6. Clinical Colorectal Cancer (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (6)
  2. Elsevier Inc. (3)
  3. Springer (2)
  4. Wiley Blackwell (2)
  5. Bioscientifica Ltd (1)
  6. Elsevier B.V (1)

More Publishers

Results (20)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Noninvasive assessment of programmed-death ligand-1 (PD-L1) in esophagogastric (EG) cancer using (18)F-BMS-986229 PET
    Meeting Abstract

    Cytryn, S. L.; Pandit-Taskar, N.; Maron, S. B.; Gu, P.; Ku, G. Y.; Chou, J. F.; Capanu, M.; Feder, L.; Philemond, S.; Lyashchenko, S. K.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • (18)F-BMS-986229 PET to assess programmed-death ligand 1 status in gastroesophageal cancer
    Journal Article

    Cytryn, S. L.; Pandit-Taskar, N.; Lumish, M. A.; Maron, S. B.; Gu, P.; Ku, G. Y.; Chou, J. F.; Capanu, M.; Antoine, A.; Loegel, D.; more...
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: A single-arm, single-centre, phase 2 trial
    Journal Article

    Cytryn, S. L.; Moy, R. H.; Cowzer, D.; Shah, R. H.; Chou, J. F.; Joshi, S. S.; Ku, G. Y.; Maron, S. B.; Desai, A.; Yang, J.; more...
    Lancet Oncology (2023)

    Fulltext@MSK | Save
  • Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer
    Journal Article

    Rojas, L. A.; Sethna, Z.; Soares, K. C.; Olcese, C.; Pang, N.; Patterson, E.; Lihm, J.; Ceglia, N.; Guasp, P.; Chu, A.; more...
    Nature (2023)

    Fulltext@MSK | Save
  • Regorafenib (REGO) with nivolumab (NIVO) and FOLFOX in HER2 negative esophagogastric cancer (EGC)
    Meeting Abstract

    Cytryn, S.; Joshi, S.; Ku, G. Y.; Maron, S. B.; Desai, A.; Yang, J.; Rao, D.; Goldberg, Z.; Sugarman, R.; Antoine, A.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Hepatoid esophagogastric adenocarcinoma and tumoral heterogeneity: A case report
    Journal Article

    de Castria, T. B.; Tang, L.; Moro Queiroz, M.; Mendes Awni, B.; Paroder, V.; Shamseddine, A.; Mendonca Bariani, G.; Mukherji, D.; Matar, C. F.; dos Santos Fernandes, G.; more...
    Journal of Gastrointestinal Oncology (2021)

    Fulltext@MSK | Save
  • Ribociclib and everolimus in well-differentiated foregut neuroendocrine tumors
    Journal Article

    Raj, N.; Zheng, Y.; Hauser, H.; Chou, J.; Rafailov, J.; Bou-Ayache, J.; Sawan, P.; Chaft, J.; Chan, J.; Perez, K.; more...
    Endocrine-Related Cancer (2021)

    Fulltext@MSK | Save
  • Systemic chemotherapy for metastatic colitis-associated cancer has a worse outcome than sporadic colorectal cancer: Matched case cohort analysis
    Journal Article

    Yaeger, R.; Paroder, V.; Bates, D. D. B.; Capanu, M.; Chou, J.; Tang, L.; Chatila, W.; Schultz, N.; Hersch, J.; Kelsen, D.
    Clinical Colorectal Cancer (2020)

    Fulltext@MSK | Save
  • Outcomes for matched patients with metastatic colitis-associated cancers versus sporadic colorectal cancer receiving chemotherapy
    Meeting Abstract

    Yaeger, R.; Hersch, J.; Bates, D.; Paroder, V.; Chou, J. F.; Tang, L. H.; Gollub, M. J.; Capanu, M.; Kelsen, D. P.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Phase 1 trial evaluating cisplatin, gemcitabine, and veliparib in 2 patient cohorts: Germline BRCA mutation carriers and wild-type BRCA pancreatic ductal adenocarcinoma
    Journal Article

    O'Reilly, E. M.; Lee, J. W.; Lowery, M. A.; Capanu, M.; Stadler, Z. K.; Moore, M. J.; Dhani, N.; Kindler, H. L.; Estrella, H.; Maynard, H.; more...
    Cancer (2018)

    Fulltext@MSK | Save